|
|
Recent Articles
-
Dividend Increases/Decreases for the Week of December 20
Dec 20, 2024
-
Let's take a look at firms raising/lowering their dividends this week.
-
Shares of UnitedHealth Group and Vertex Pharma Sour
Dec 19, 2024
-
Image Source: Rodrigo Senna cc by 2.0.
As of right now, we continue to monitor the situation with UnitedHealth, but the risks have substantially increased. We have no plans to remove it from the Best Ideas Newsletter portfolio at this time as we await news flow to settle down. As for Vertex, we continue to like its established position in cystic fibrosis and its opportunity in gene-editing therapies as well as a new class of medicine for acute pain that’s without the limitations of opioids. Though the news regarding suzetrigine wasn’t what the market was hoping for, the company’s pipeline is progressing nicely.
-
Dividend Increases/Decreases for the Week of December 13
Dec 13, 2024
-
Let's take a look at firms raising/lowering their dividends this week.
-
Adobe Issues Cautious Fiscal 2025 Guidance
Dec 12, 2024
-
Image Source: Adobe.
Looking to fiscal 2025, Adobe expects total revenue in the range of $23.30-$23.55 billion, below the $23.8 billion consensus estimate. Digital Media segment revenue is targeted at $17.25-$17.4 billion, with ending ARR growth of 11% year-over-year, while Digital Experience segment revenue is expected to be between $5.8-$5.9 billion. Non-GAAP earnings per share is expected in the range of $20.20-$20.50 for the year, the midpoint below the consensus estimate of $20.52. Adobe ended the quarter with $7.9 billion in cash and short-term investments, while debt totaled $5.6 billion, good for a nice net cash position. We like Adobe, but its cautious outlook for 2025 keeps us on the sidelines.
|
